Feasibility of novel adult tuberculosis vaccination in South Africa: a cost-effectiveness and budget impact analysis. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41541-022-00554-1
PubMed Identifier: 36344523
Publication URI: http://europepmc.org/abstract/MED/36344523
Type: Journal Article/Review
Volume: 7
Parent Publication: NPJ vaccines
Issue: 1
ISSN: 2059-0105